Old Web
English
Sign In
Acemap
>
authorDetail
>
Satterly Kelsey H
Satterly Kelsey H
Medicine
Bioavailability
Tolerability
Dosing
Dihydroergotamine Mesylate
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Preclinical Development of a Novel Precision Olfactory Delivery (POD®) - L-dopa Drug-Device Combination Product for the Treatment of OFF Episodes in Parkinson’s Disease (P2.8-049)
2019
Neurology
Satterly Kelsey H
Greg Davies
Bhavin Y. Gajera
Jennifer Wright
Hong Lin
Shweta Muppaneni
Khang To
Dashevsky Inna
Stephen B. Shrewsbury
John Hoekman
Show All
Source
Cite
Save
Citations (0)
Precision Olfactory Delivery (POD®) of Drugs for Neurological Disease: A Safety, Tolerability and Comparative Bioavailability Study of POD Dihydroergotamine Mesylate (INP104) to Approved IV D.H.E. 45® and Migranal® Nasal Spray. (P2.10-022)
2019
Neurology
Stephen B. Shrewsbury
Maria Jeleva
Jason Lickliter
Satterly Kelsey H
John Hoekman
Show All
Source
Cite
Save
Citations (0)
1